Insider Transactions in Q3 2025 at Nuvalent, Inc. (NUVL)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 07
2025
|
Henry E. Pelish Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,500
-8.28%
|
$407,000
$74.85 P/Share
|
|
Aug 07
2025
|
Henry E. Pelish Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+2.7%
|
$137,500
$25.37 P/Share
|
|
Jul 30
2025
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,000
-7.69%
|
$320,000
$80.36 P/Share
|
|
Jul 30
2025
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+7.14%
|
$108,000
$27.85 P/Share
|
|
Jul 16
2025
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,700
-19.23%
|
$1,249,500
$85.1 P/Share
|
|
Jul 16
2025
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,700
+16.13%
|
$264,600
$18.93 P/Share
|
|
Jul 15
2025
|
James Richard Porter President and CEO |
SELL
Open market or private sale
|
Direct |
27,000
-2.5%
|
$2,241,000
$83.11 P/Share
|
|
Jul 15
2025
|
James Richard Porter President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,000
+8.91%
|
$486,000
$18.93 P/Share
|
|
Jul 15
2025
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,300
-2.03%
|
$445,200
$84.23 P/Share
|
|
Jul 15
2025
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+7.33%
|
$95,400
$18.93 P/Share
|
|
Jul 10
2025
|
Henry E. Pelish Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,500
-4.15%
|
$440,000
$80.43 P/Share
|
|
Jul 10
2025
|
Henry E. Pelish Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+2.65%
|
$137,500
$25.37 P/Share
|
|
Jul 09
2025
|
Henry E. Pelish Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,145
-1.7%
|
$173,745
$81.49 P/Share
|